Clopidogrel Resinate
氯吡格雷树脂酸盐
Report date: 2022/08/29 20:00:24
NME
Base Information
Drug NameClopidogrel Resinate
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2007/01/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesChong Kun Dang Pharmaceutical Corp
China Registration ClassN/A
Develop Information
Active CompaniesChong Kun Dang Pharmaceutical Corp
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A